WHITNEY ROBERTS: Open Payments
NPI 1396204772 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 31 payments from 14 companies in 2025. Trend: 2023 $807 · 2024 $790 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Lumenis BE inc | 1 | $223 |
| Novo Nordisk Inc | 6 | $108 |
| Phathom Pharmaceuticals, Inc. | 3 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
Products named: M22, VOQUEZNA, DUPIXENT, AIRSUPRA, NEFFY, Rybelsus, TRELEGY ELLIPTA, Kerendia.
Industry payments across GA — which companies pay providers there.
